Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMicallef, Darren-
dc.contributor.authorMicallef, Sarah-
dc.contributor.authorSchembri-Wismayer, Pierre-
dc.contributor.authorCalleja-Agius, Jean-
dc.identifier.citationMicallef, D., Micallef, S., Schembri-Wismayer, P., & Calleja-Agius, J. (2016). Novel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancer. Journal of the Turkish German Gynecological Association, 17(4), 214.en_GB
dc.description.abstractRecent evidence shows that commonly prescribed drugs, such as non-steroidal anti-inflammatory drugs (NSAIDs), metformin, and statins, may have beneficial roles in the primary chemoprevention of breast cancer. Therefore, these drugs could potentially be used in addition to the hormonal drugs currently used for this purpose (namely, selective estrogen receptor modulators and aromatase inhibitors) due to their alternative mechanisms of action.en_GB
dc.publisherAVES İbrahim KARAen_GB
dc.subjectBreast neoplasmsen_GB
dc.subjectHydroxymethylglutaryl-CoA Reductase Inhibitorsen_GB
dc.subjectBreast -- Canceren_GB
dc.titleNovel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast canceren_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.publication.titleJournal of the Turkish German Gynecology Associationen_GB
Appears in Collections:Scholarly Works - FacM&SAna

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.